Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Sagaert

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 24, 2013
DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotypeVeerle De Vriendt, Wendy De Roock, Antonio Fabio Di Narzo, et al.
Journal of Autoimmunity|March 8, 2011
Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune diseaseBénédicte Cauwe, Erik Martens, Xavier Sagaert, et al.
Elife|August 3, 2014
Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaksHui Zhao, Bernard Thienpont, Betül Tuba Yesilyurt, et al.
Science (New York, N.Y.)|January 29, 2011
Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activationShaun Rosebeck, Lisa Madden, Xiaohong Jin, et al.
British Journal of Cancer|November 25, 2016
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switchingLinde De Smedt, Sofie Palmans, Daan Andel, et al.
Cancer Immunology, Immunotherapy : CII|February 17, 2021
Correction to: In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapyLukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, et al.
Leukemia & Lymphoma|February 28, 2013
Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factorsDaan Dierickx, Thomas Tousseyn, Xavier Sagaert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST studyEric Van Cutsem, Sabine Tejpar, Dirk Vanbeckevoort, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 5, 2026
Young onset rectal cancer (YORC): a descriptive tertiary center analysisCédric Schraepen, Gertjan Rasschaert, Pieter Maerten, et al.
Haematologica|October 16, 2012
The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorderDaan Dierickx, Thomas Tousseyn, Annelies Requilé, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 24, 2013
DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotypeVeerle De Vriendt, Wendy De Roock, Antonio Fabio Di Narzo, et al.
Journal of Autoimmunity|March 8, 2011
Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune diseaseBénédicte Cauwe, Erik Martens, Xavier Sagaert, et al.
Elife|August 3, 2014
Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaksHui Zhao, Bernard Thienpont, Betül Tuba Yesilyurt, et al.
Science (New York, N.Y.)|January 29, 2011
Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activationShaun Rosebeck, Lisa Madden, Xiaohong Jin, et al.
British Journal of Cancer|November 25, 2016
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switchingLinde De Smedt, Sofie Palmans, Daan Andel, et al.
Cancer Immunology, Immunotherapy : CII|February 17, 2021
Correction to: In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapyLukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, et al.
Leukemia & Lymphoma|February 28, 2013
Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factorsDaan Dierickx, Thomas Tousseyn, Xavier Sagaert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST studyEric Van Cutsem, Sabine Tejpar, Dirk Vanbeckevoort, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 5, 2026
Young onset rectal cancer (YORC): a descriptive tertiary center analysisCédric Schraepen, Gertjan Rasschaert, Pieter Maerten, et al.
Haematologica|October 16, 2012
The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorderDaan Dierickx, Thomas Tousseyn, Annelies Requilé, et al.
Pageof 10